Chromologic LLC SBIR Phase I Award, May 2022

A SBIR Phase I contract was awarded to Chromologic Llc in May, 2022 for $249,999.0 USD from the U.S. Department of Defense and Defense Health Agency.

Overview Structured Data Issues Contributors Activity

sbir.gov/node/2327713

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

Chromologic Llc

Government Agency

U.S. Department of Defense

Government Branch

Defense Health Agency

Award Type

SBIR0

Contract Number (US Government)

W81XWH22P00630

Award Phase

Phase I0

Award Amount (USD)

249,9990

Date Awarded

May 31, 2022

End Date

January 1, 2023

Abstract

In order to meet DHA’s need for quantitative imaging of the olfactory neuroepithelium (ON) ChromoLogic proposes to develop a Neuroepithelial Optical Coherence Tomography (NOCT) system that uses an optical coherence tomography (OCT) endoscope to generate 3D images of the ON. The device is non-invasive and can be used to determine the cellular and functional characteristics of olfactory neuroepithelium with limited anesthesia. The device can determine thickness of the mucus layer, epithelium, and the lamina propria and characterize important properties of the cellular layers. This is made possible by a custom-designed OCT probe that can be inserted into the nose for high resolution imaging and analysis software that can quantify the thickness of the various layers from the resulting 3D images.